
Quantum BioPharma fell 80.0% from $7.21 to $1.44, behind the S&P 500's +11.2%. Its worst day was Mar 11 (−25.0%), and its low came Nov 16 at $1.44.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Quantum BioPharma closed at its highest level of the year, 58.3% above where the year started.
+41.9% · S&P 500 +0.7%
Quantum BioPharma shares fell 25.0%, while the S&P 500 fell 0.1%.
−25.0%, the year's worst day · S&P 500 −0.1%
Story events cover the past 12 months · Times ET
EPS of $-0.71 beat the $-0.93 estimate on $0.00 revenue (est. $1.2M).
+24.5% · S&P 500 −1.7%
Quantum BioPharma shares rose 23.3%, while the S&P 500 rose 0.2%.
+23.3% · S&P 500 +0.2%
EPS of $-3.06 missed the $-0.56 estimate on $0.00 revenue (est. $1.5M).
−5.1% · S&P 500 −0.3%
Quantum BioPharma shares fell 23.7%, while the S&P 500 rose 0.7%.
−23.7% · S&P 500 +0.7%
EPS of $-0.47 beat the $-0.51 estimate on $0.00 revenue.
+17.6% · S&P 500 −0.2%
EPS of $-0.06 beat the $-0.63 estimate on $0.00 revenue.
−8.2% · S&P 500 −0.4%
Where it ended: a close of $1.44 on Nov 16, 2026.
Nothing in the past 12 months.
All QNTM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for QNTM and SPY from Benzinga historical bars. Not investment advice.